Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNTHESIS
NCT00540527Phase 3Completed
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Jan 2004
- Primary completion
- Jan 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by ASST Grande Ospedale Metropolitano Niguarda. Started Jan 2004; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00540527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540527.